Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Table 4 Association of alanine aminotransferase level, all-cause, cardiovascular disease, cancer-related and others-related mortality among nonalcoholic fatty liver disease patients in men
Mortality outcome, ALT level
No. of death, n (%)
Unadjusted
Age-adjusted
Multivariate-adjusted
HR (95%CI)
P value
HR (95%CI)
P value
HR (95%CI)
P value
All-cause
< 0.5 ULN306 (61.1)111
0.5-1 ULN436 (45.2)0.60 (0.52-0.70)< 0.0010.69 (0.59-0.80)< 0.0010.68 (0.58-0.80)< 0001
1-2 ULN115 (30.8))0.37 (0.30-0.46)< 0.0010.62 (0.50-0.77)< 0.0010.60 (0.47-0.76)< 0001
≥ 2 ULN21 (22.6)0.26 (0.16-0.40)< 0.0010.69 (0.44-1.09)0.110.72 (0.42-1.21)0.214
Cardiovascular disease
< 0.5 ULN102 (20.4)111
0.5-1 ULN119 (22.3)0.50 (0.39-0.65)< 0.0010.58 (0.44-0.76)< 0.0010.57 (0.43-0.77)< 0.001
1-2 ULN34 (9.1)0.34 (0.23-0.50)< 0.0010.58 (0.39-0.87)0.0070.55 (0.33-0.92)0.022
≥ 2 ULN3 (3.2)0.11 (0.04-0.36)< 0.0010.33 (0.10-1.05)0.060.51 (0.13-1.97)0.331
Cancer
< 0.5 ULN67 (13.4)111
0.5-1 ULN103 (10.7)0.65 (0.48-0.89)0.0060.73 (0.54-1.00)0.0510.79 (0.57-1.10)0.169
1-2 ULN25 (6.7)0.37 (0.23-0.58)< 0.0010.62 (0.39-0.99)0.0470.76 (0.45-1.29)0.308
≥ 2 ULN5 (5.4)0.28 (0.11-0.69)0.0060.81 (0.32-2.05)0.6541.05 (0.35-3.12)0.935
Others
< 0.5 ULN137 (44.8)111
0.5-1 ULN214 (49.1)0.81 (0.65-1.00)0.0480.81 (0.66-1.01)0.0580.73 (0.57-0.92)0.921
1-2 ULN56 (48.7)0.68 (0.50-0.92)0.0140.75 (0.55-1.03)0.0730.57 (0.38-0.85)0.851
≥ 2 ULN13 (61.9)0.70 (0.39-1.23)0.2120.76 (0.42-1.37)0.3610.40 (0.19-0.84)0.844